My six-month longevity gene therapy results are in... 

In Sept 2023, I traveled to Roatan, an island off the coast of Honduras, to receive follistatin gene therapy. 

Humans currently have a max lifespan of roughly 120 years. However gene therapies have the potential to help break through that barrier. Follistatin gene therapy ranks 7th among lifespan studies, extending mouse lifespan by over 30%. 

My 71-year-old father also received the gene therapy. He’s awaiting his six month results.

My longevity gene therapy results:

+ My speed of aging has dropped to 0.64 (a personal best). I now celebrate my birthday every 19 months. 
+ My muscle mass is up by 7% (already in the 99th percentile)
+ My follistatin levels increased by 160% (2 weeks post-injection) 

Sleep, diet, and exercise remain foundational. These next-generation therapies further bolster our chances of being the first generation that has the choice of saying yes to continuous tomorrows. 

Full video https://youtu.be/bax8to_s07Q

I don't want to die soon but market wants me to, we live in a crazy world!

gm, sorry fellas. alpha drop soon
kinda busy this week

gm degens, distribution phase. don't let them fool you in selling!

RBN/AEVO interesting arbitrage opportunity. RBN is trading at $1.67 vs $2.6 AEVO. RBN to AEVO will be converted to 1:1 after migration in two months. Here's the arb:
- Long RBN
- Short AEVO (Although funding rates for AEVO are still high)

$AXS did 1600x last cycle. What is the Axie-Infinity of this cycle?

Funding Rate Arbitrage: The basic idea is to maintain equally long and short positions on an asset in order to accrue interest from the funding rate. Funding rates gets multiplied by leverage. 5x leverage = 5x Funding rate so a 20% yield becomes 100% yield at 5x leverage but that also multiplies the risk.

new account new capital
less thesis more balls

gm, I am back to crush this market with my Math

Quant | Featured in “The Big Short” 🎥 | Winner of National Math Competition | I don’t speak English